ArticleProceedings of the National Academy of Sciences of the United States of America2020

Reply to Han et al.: On track for an IDO1-based personalized therapy in autoimmunity.

Giada Mondanelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.